The patent application protects nontoxic small molecules (glycomimetics), easily obtained from natural compounds (carbohydrates), which can be used for personalized treatment of glycan-related diseases
Research Institution:
Università degli Studi di Firenze
Priorities and sectors:
Life Sciences
